FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
PROLIFE
INDUSTRIES LIMITED
Our Company was incorporated as Mamta Dyes and intermediaries Private Limited under the provision of the Companies Act, 1956 vide certificate of incorporation dated July 27 1994 issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Consequent upon the conversion of our Company to public limited company, the name of our Company was changed to Mamta Dyes and Intermediaries Limited and fresh certificate of incorporation dated February 20,1997 was issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli Subsequently, the name of our Company was changed to R R J-Dyes and Intermediates Limited vide fresh certificate of incorporation dated February 20, 1997 was issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Later on the name of the company was changed to Prolife Industries Limited and fresh certificate of Incorporation dated March 7, 2013 pursuant to change of name was issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli. The Corporate Identification Number of our Company is U24231GJ1994PLC022613. Registered office: 213, G.I.D.C., Panoli, Ankleshwar - 394 116,
Gujarat; Tel:- +91-2646-272490; Website: www.prolifeindustries.in BASIS OF ALLOTMENT PUBLIC ISSUE OF 11,10,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH OF PROLIFE INDUSTRIES LIMITED ('PIL' OR THE 'COMPANY' OR THE 'ISSUER') FOR CASH AT A PRICE OF RS 38 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 28 PER EQUITY SHARE (THE 'ISSUE PRICE') AGGREGATING TO RS 421.80 LACS ('THE ISSUE'), OF WHICH 60,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH WILL FOR CASH AT A PRICE OF RS 38 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 28 PER EQUITY SHARE AGGREGATING TO RS 22,80 LACS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER TO THE ISSUE (THE 'MARKET MAKER RESERVATION PORTION'). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION i.e. NET ISSUE OF 10,50,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH AT A PRICE OF RS 38 PER EQUITY SHARE AGGREGATING TO RS 399.00 LACS IS HEREIN AFTER REFERREO TO AS THE 'NET ISSUE'. THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 27.11% AND 25.65%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY. In terms of Prospectus dated December 20, 2016 and as per Regulation 43 (4) of SEBI (ICDR) Regulations, 2009 wherein a minimum of 50 % of the Net Offer to Public shall be initially made available to Retail Individual Investors as the case may be. The balance net offer of shares to the public shall be made available for allotment to a) individual applicants other than retail investors and b) other investors including corporate bodies / institutions irrespective of no. of shares applied for. Explanation: For the purpose of Regulation 43 (4) of SEBI (ICDR) Regulations, 2009, if the retail individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage. THE FACE VALUE OF THE EQUITY SHARES IS RS 10/- EACH AND THE ISSUE PRICE IS RS 38/- EACH INCLUDING A SHARE PREMIUM OF RS 28 PER EQUITY SHARE. THE ISSUE PRICE IS 3.8 TIME OF THE FACE VALUE. ISSUE OPENED ON DECEMBER 27, 2016 (TUESDAY) AND CLOSED ON DECEMBER 30, 2016 (FRIDAY). The Equity Shares offered through the Prospectus are proposed to be listed on the SME platform of The NSE (Emerge) in terms of the chapter XB of the SEBI (ICDR) Regulations, 2009 as amended from time to time. The Company is not required to obtain an in-principle approval of the shares being offered in this Issue. However Company has received an observation letter dated December 16, 2016 from NSE for using its name in the offer document for listing of our Shares on the SME Platform of NSE (Emerge). The designated stock exchange is NSE. SUBSCRIPTION DETAILS Details of Applications: The Issue has received 822 applications (before technical rejections) for 48,48,000 Equity Shares (Including Market Maker Application of 60,000 Equity Shares) resulting 4.37 times subscription. The details of the applications received in the Issue (before technical rejections) are as follows: Details of the valid Applications Received (before Technical Rejections & Withdrawal of Application): _
Total 17 applications received in Retail individual investor Category were rejected on technical grounds. Further, there was no withdrawal or application in any of the category ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - National Stock Exchange Limited on January 4, 2017. A Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs 38/- per Equity Share, was finalised in consultation with NSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 60,000 Equity shares in full, out of reserved portion of 60,000 Equity Shares. B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal, if any); The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs 38/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 4.12 times. Total number of shares allotted in this category is 5,25,000 Equity Share as under:
C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs 38/- per Equity Share, was finalized in consultation with NSE The category was subscribed by 4.90 times. Total number of shares allotted in this category is 5,25,000 Equity Shares. The category wise basis of allotment is as under:
The Board of Directors of the Company at its meeting held on January 5, 2017 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for the transfer of the Equity Shares / dispatch of share certificates to various successful applicants. The CAN-cum-Refund Orders and allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories / as filled in the application form on or before January 6, 2017 Further, the instructions to Self Certified Syndicate Banks being processed on or before January 6, 2017. In case the same is not received within 10 days, investors may contact at the address given below The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of The National Stock Exchange of India Limited within Six working days from the date of the closure of the Issue. The trading is proposed to be commenced on or before January 9, 2017 subject to receipt of listing and trading approvals from the National Stock Exchange of India Limited. INVESTORS PLEASE NOTE The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Link Intime India Private Limited at www.linkintime.co.in. All future correspondence in this regard may kindly be addresses to the Registrar to the Issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below: LINK INTIME INDIA PRIVATE LIMITED
|
The IPO allocation is based on the subscription level and the investor category.
Refer to IPO allotment rules and methods for more details.
See the basis of allotment document above to know how the shares are allocated in Prolife Industries IPO .
The Prolife Industries IPO basis of allotment (published above) tells you how shares are allocated to you in Prolife Industries IPO and category wise demand of IPO share.
Visit the Prolife Industries IPO allotment status page to check the number of shares allocated to your application.
In Prolife Industries IPO allotment process, the registrar separates valid and invalid applications. The invalid applications with technical errors are rejected and only valid applications at or above the cut-off price are considered for allotment.
For more information, please refer to IPO Allotment Process and Basis of Allotment.
Check the Prolife Industries IPO basis of allotment document to know how the shares are allocated in Prolife Industries IPO.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|